Plain-English translation of NCT06272578 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This is an observational study — meaning researchers are watching and measuring, not testing a new drug or treatment. The study aims to find out how often people with chronic kidney disease develop hidden heart structural problems that they don't realize they have. Researchers will use heart ultrasounds and blood tests to look for these early signs.
People with chronic kidney disease have a much higher risk of developing heart problems, even in early stages. However, many of these heart problems develop silently without any symptoms. This study wants to understand how often this happens so doctors can potentially catch and treat these problems earlier.
You likely qualify if…
You likely don't qualify if…
You will visit the study center once for a comprehensive evaluation. During this visit, you'll have a heart ultrasound (echocardiogram) to look at your heart's structure and function, and researchers will take blood samples for advanced protein analysis. The visit will also include a review of your medical history and a physical exam. The entire study is observational — you won't receive any medication or treatment as part of this research.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Germany
Collaborators
AstraZeneca
Enrollment target
~400 participants
Started
March 2024
Primary completion
February 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Daniela Zurkan
German Heart Institute
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.